In conclusion, the serum miR-106 content of patients with AF was prominently higher than that of healthy people and the MYL4 content was signally lower than that of healthy people, suggesting that abnormal serum miR-106 and MYL4 levels may predict the risk of AF. This evidence concerns the gene MYL4 and atrial fibrillation.